Allogeneic stem cell transplantation in high-risk relapse of aggressive lymphoma. Results of a prospective phase II study

被引：0
|
作者：
Glass, B.
Hasenkamp, J.
Goerlitz, A.
Dreger, P.
Schubert, J.
Wulf, G.
Nickelsen, M.
Truemper, L.
Schmitz, N.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [1] Post-transplant rituximab reduces relapse risk after allogeneic and autologous stem-cell transplantation (SCT) in high-risk aggressive lymphoma.
    Shimoni, A
    Hardan, I
    Avigdor, A
    Yeshurun, M
    Raanani, P
    Ben-Bassat, I
    Nagler, A
    BLOOD, 2002, 100 (11) : 178A - 178A
  • [2] Allogeneic peripheral blood stem cell transplantion for treatment of high-risk relapse of aggressive lymphoma.: Interim analysis of the DSHNHL R3 study
    Glass, B.
    Hasenkamp, J.
    Dreger, P.
    Gramatzki, M.
    Schubert, J.
    Wulf, G.
    Nickelsen, M.
    Truemper, L.
    Schmitz, N.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S242 - S243
  • [3] Rituximab for Graft-Versus-Host-Disease-Prophylaxis after Allogeneic Stem Cell Transplantation Given as Treatment of High Risk Relapse of Aggressive Lymphoma: Results of a Randomized Phase II Study
    Glass, Bertram
    Hasenkamp, Justin
    Goerlitz, Anke
    Dreger, Peter
    Schubert, Joerg
    Wulf, Gerald
    Nickelsen, Maike
    Truemper, Lorenz H.
    Schmitz, Norbert
    BLOOD, 2008, 112 (11) : 689 - 690
  • [4] Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma
    Shimoni, A
    Hardan, I
    Avigdor, A
    Yeshurun, M
    Raanani, P
    Ben-Bassat, I
    Nagler, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (03) : 457 - 464
  • [5] Allogeneic Stem Cell Transplantation Results in a Low Relapse Rate in Patients with Peripheral T-Cell Lymphoma.
    Nickelsen, Maike
    Canals, Carmen, Sr.
    Kyriakou, Charalampia
    Schmitz, Norbert
    Buzyn, Agnes
    Engelhardt, Monika
    Glass, Bertram
    Conde, Eulogio
    Lopez-Guillermo, Armando
    Socie, Gerard
    Sureda, Anna
    BLOOD, 2008, 112 (11) : 358 - 359
  • [6] Allogeneic blood stem cell transplantation for patients with end-stage lymphoma. A prospective study
    vanBesien, K
    Khouri, I
    Korbling, M
    Thall, P
    Mehra, R
    Giralt, S
    Mirza, N
    Williams, P
    Przepiorka, D
    Gajewski, J
    Andersson, B
    Champlin, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 979 - 979
  • [7] A Phase II Study of Decitabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Patients with Myeloid Malignancies
    D'Angelo, Christopher R.
    Hall, Aric C.
    Kim, Kyungmann
    Mattison, Ryan J.
    Longo, Walter L.
    Hematti, Peiman
    Callander, Natalie Scott
    Juckett, Mark
    BLOOD, 2018, 132
  • [8] Intermediate intensity conditioning and T-cell replete allogeneic transplantation is effective in high-risk relapse and progressive disease of aggressive lymphoma
    Hasenkamp, J.
    Wulf, G.
    Goerlitz, A.
    Dreger, P.
    Schubert, J.
    Nickelsen, M.
    Truemper, L.
    Schmitz, N.
    Glass, B.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S249 - S249
  • [9] Allogeneic Stem Cell Transplantation with Intermediate Conditioning Is Effective in High Risk Relapse and Progressive Disease of Aggressive Non-Hodgkin-Lymphoma
    Glass, Bertram
    Hasenkamp, Justin
    Goerlitz, Anke
    Dreger, Peter
    Schubert, Joerg
    Wulf, Gerald
    Nickelsen, Maike
    Truemper, Lorenz H.
    Schmitz, Norbert
    BLOOD, 2009, 114 (22) : 1312 - 1312
  • [10] Impact of AECC regiment with autologous stem cell transplantation for patients with high risk of relapse and refractory aggressive non-Hodgkin's lymphoma.
    Yano, S
    Asai, O
    Dobashi, N
    Sugiyama, K
    Saito, T
    Sekiguchi, N
    Kato, A
    Yahagi, Y
    Hoshi, Y
    Usui, N
    Kobayashi, M
    BLOOD, 2002, 100 (11) : 473B - 474B
12345